CN Stock MarketDetailed Quotes
002750 Kunming Longjin Pharmaceutical
- 1.90
- +0.09+4.97%
Market Closed Jul 17 15:00 CST
760.95MMarket Cap-11309P/E (TTM)
1.90High1.86Low92.64KlotVolume1.86Open1.81Pre Close17.52MTurnover2.32%Turnover RatioLossP/E (Static)400.50MShares12.5052wk High1.50P/B757.60MFloat Cap1.4352wk Low1.90Limit Up398.74MShs Float26.32Historical High1.72Limit Down2.21%Amplitude1.43Historical Low--Dividend TTM1.89Avg Price49.53KlotAsk--Div YieldTTM100Lot Size33.98KlotBid
Kunming Longjin Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -18.26%21.71M | -31.60%103.38M | -31.92%81.91M | -39.02%54.46M | -51.41%26.56M | -75.38%151.14M | -76.93%120.32M | -71.73%89.32M | -60.95%54.66M | 125.53%613.92M |
| Refunds of taxes and levies | ---- | ---- | ---- | --0 | ---- | --1.4M | --1.4M | --1.4M | ---- | ---- |
| Net deposit increase | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net increase in borrowings from central bank | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net increase in placements from other financial institutions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received from interests, fees and commissions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net increase in repurchase business capital | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Premiums received from original insurance contracts | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash received from reinsurance business | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net increase in deposits from policyholders | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net increase in funds disbursed | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash received from trading securities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other operating activities | 78.39%3.56M | -15.61%18.87M | -71.11%6.07M | -38.28%3.97M | -25.08%2M | -32.17%22.36M | 12.67%21.02M | -57.86%6.43M | -77.25%2.66M | 36.08%32.96M |
| Cash inflows from operating activities | -11.50%25.27M | -30.10%122.25M | -38.36%87.98M | -39.85%58.43M | -50.19%28.56M | -72.96%174.9M | -73.58%142.74M | -70.67%97.14M | -62.21%57.32M | 118.22%646.88M |
| Goods services cash paid | -10.87%3.56M | 1.05%17.89M | -37.96%8.93M | -42.32%6.35M | -46.02%4M | -95.48%17.7M | -96.00%14.39M | -95.10%11.01M | -93.86%7.41M | 549.07%391.89M |
| Staff behalf paid | 10.55%10.3M | 12.28%31.59M | 12.34%24.36M | 14.17%16.45M | 31.71%9.32M | -33.85%28.14M | -37.63%21.69M | -37.78%14.41M | -37.23%7.08M | 69.19%42.54M |
| All taxes paid | -75.22%2.36M | 57.55%20.67M | 54.83%18.78M | 111.67%14.96M | 161.92%9.52M | -56.45%13.12M | -49.13%12.13M | -55.43%7.07M | -47.03%3.64M | -4.41%30.12M |
| Net loan and advance increase | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net deposit in central bank and institutions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net lend capital | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid for fees and commissions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid for indemnity of original insurance contract | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Policy dividend cash paid | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other operating activities | -68.69%13.81M | -29.93%91.36M | -23.71%83.81M | -25.28%61.87M | -10.69%44.11M | -33.86%130.38M | -21.40%109.85M | -10.89%82.8M | 10.43%49.39M | 5.89%197.14M |
| Cash outflows from operating activities | -55.14%30.04M | -14.70%161.51M | -14.03%135.88M | -13.58%99.63M | -0.83%66.95M | -71.38%189.34M | -71.69%158.05M | -67.68%115.29M | -63.21%67.51M | 118.22%661.69M |
| Net cash flows from operating activities | 87.59%-4.76M | -171.83%-39.26M | -212.80%-47.89M | -127.09%-41.2M | -276.88%-38.4M | 2.44%-14.44M | 14.87%-15.31M | 28.78%-18.14M | 67.97%-10.19M | -118.45%-14.8M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 48.51%334.15M | 18.03%1.34B | 27.31%1B | 33.64%703M | 4.41%225M | 0.86%1.14B | -2.98%788.06M | 3.49%526.03M | -27.32%215.5M | 4.16%1.13B |
| Cash received from returns on investments | -40.58%905.57K | -33.85%6.2M | -35.52%4.41M | -36.07%2.86M | -10.00%1.52M | 2.54%9.37M | 4.13%6.84M | 13.58%4.47M | -25.00%1.69M | -6.98%9.14M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | ---- | ---- | --0 | ---- | -17.18%343.2K | 200.69%350K | 268.42%350K | ---- | 20.38%414.4K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | --0 | ---- | 51.06%17.71M | --14.29M | ---- | ---- | --11.73M |
| Cash received relating to other investing activities | ---- | --1.3M | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 47.91%335.06M | 15.90%1.35B | 24.47%1.01B | 32.97%705.86M | 4.30%226.52M | 1.38%1.17B | -1.15%809.55M | 3.61%530.85M | -27.32%217.19M | 5.14%1.15B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -45.36%2.35M | -37.89%15.67M | -38.94%12.1M | 42.92%9.89M | 175.90%4.29M | 143.65%25.22M | 95.61%19.81M | -8.07%6.92M | -62.05%1.56M | -56.16%10.35M |
| Cash paid to acquire investments | 86.23%419.01M | 22.34%1.25B | 31.06%1.04B | 51.06%742M | 2.18%225M | -12.36%1.03B | -5.53%796.2M | -6.58%491.2M | -18.14%220.2M | 0.29%1.17B |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | --5.05M | --5.05M | --6.35M | ---- | ---- | ---- | ---- | ---- |
| Impawned loan net increase | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | --25.99M | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | 78.81%421.36M | 23.36%1.3B | 29.98%1.06B | 51.96%756.95M | 6.26%235.65M | -10.99%1.05B | -4.33%816.01M | -6.60%498.12M | -18.80%221.76M | -0.83%1.18B |
| Net cash flows from investing activities | -846.04%-86.3M | -51.69%56.04M | -720.49%-52.99M | -256.10%-51.09M | -99.94%-9.12M | 492.30%116M | 80.97%-6.46M | 255.86%32.73M | -117.72%-4.56M | 69.11%-29.57M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | --14.6M | --3.09M | --0 | ---- | ---- | ---- | ---- | ---- | -52.55%14.77M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | --14.6M | --3.09M | --0 | ---- | ---- | ---- | ---- | ---- | -52.55%14.77M |
| Cash from borrowing | --9.98M | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | --10M |
| Cash received relating to other financing activities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | --9.98M | --14.6M | --3.09M | --0 | ---- | ---- | ---- | ---- | ---- | -20.43%24.77M |
| Borrowing repayment | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Dividend interest payment | ---- | --47.52K | --47.52K | --47.52K | ---- | ---- | ---- | ---- | ---- | --393.59K |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | --47.52K | --47.52K | --47.52K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | ---- | -6.81%11.67M | ---- | --0 | ---- | 544.98%12.52M | ---- | ---- | ---- | 2,797.83%1.94M |
| Cash outflows from financing activities | ---- | -6.43%11.72M | --47.52K | --47.52K | ---- | 436.26%12.52M | ---- | ---- | ---- | 3,385.28%2.34M |
| Net cash flows from financing activities | --9.98M | 123.04%2.89M | --3.04M | ---47.52K | ---- | -155.82%-12.52M | ---- | ---- | ---- | -27.78%22.43M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net increase in cash and cash equivalents | -70.64%-81.08M | -77.91%19.66M | -349.45%-97.84M | -733.21%-92.34M | -222.15%-47.52M | 505.83%89.03M | 28.68%-21.77M | 158.98%14.58M | -294.28%-14.75M | 69.30%-21.94M |
| Add:Begin period cash and cash equivalents | 10.29%210.74M | 87.25%191.07M | 87.25%191.07M | 87.25%191.07M | 87.25%191.07M | -17.70%102.04M | -17.70%102.04M | -17.70%102.04M | -17.70%102.04M | -36.56%123.98M |
| End period cash equivalent | -9.68%129.65M | 10.29%210.74M | 16.15%93.23M | -15.34%98.73M | 64.46%143.55M | 87.25%191.07M | -14.11%80.27M | 17.50%116.62M | -33.66%87.29M | -17.70%102.04M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | China Audit Zhonghuan Certified Public Accountants (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg